Your browser doesn't support javascript.
loading
Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
Sun, Yuqian; Hu, Jiong; Huang, He; Chen, Jing; Li, Jianyong; Ma, Jun; Li, Juan; Liang, Yingmin; Wang, Jianmin; Li, Yan; Yu, Kang; Hu, Jianda; Jin, Jie; Wang, Chun; Wu, Depei; Xiao, Yang; Huang, Xiaojun.
Afiliação
  • Sun Y; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University Institute of Hematology, Peking University, People's Hospital, Beijing, People's Republic of China.
  • Hu J; Blood and Marrow Transplantation Center, Department of Hematology, Collaborative Innovation Center of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huang H; The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, People's Republic of China.
  • Chen J; Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai, People's Republic of China.
  • Li J; Jiangsu Province Hospital, Nanjing, People's Republic of China.
  • Ma J; Harbin Hematologic Tumor Institution, Harbin, People's Republic of China.
  • Li J; The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Liang Y; Tangdu Hospital, Fourth Military Medical University, Xi'an, People's Republic of China.
  • Wang J; Changhai Hospital of the Second Military Medical University, Shanghai, People's Republic of China.
  • Li Y; The First Affiliated Hospital of China Medical University, Shengyang, People's Republic of China.
  • Yu K; The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, People's Republic of China.
  • Hu J; Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
  • Jin J; The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, People's Republic of China.
  • Wang C; The First People's Hospital of Shanghai, Shanghai, People's Republic of China.
  • Wu D; The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Xiao Y; The General Hospital of Guangzhou Military Command of PLA, Guangzhou, People's Republic of China.
  • Huang X; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University Institute of Hematology, Peking University, People's Hospital, Beijing, People's Republic of China.
Transpl Infect Dis ; 23(4): e13611, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33825274
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Infecções Fúngicas Invasivas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Humans Idioma: En Revista: Transpl Infect Dis Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de publicação: Dinamarca
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Infecções Fúngicas Invasivas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Humans Idioma: En Revista: Transpl Infect Dis Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de publicação: Dinamarca